News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
288,568 Results
Type
Article (15671)
Company Profile (283)
Press Release (272614)
Section
Business (84962)
Career Advice (167)
Deals (14324)
Drug Delivery (35)
Drug Development (52750)
Employer Resources (31)
FDA (6426)
Job Trends (5461)
News (154328)
Policy (11012)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (1000)
Accelerated approval (3)
Adcomms (12)
Allergies (55)
Alliances (23248)
ALS (62)
Alzheimer's disease (875)
Antibody-drug conjugate (ADC) (89)
Approvals (6454)
Artificial intelligence (113)
Autoimmune disease (13)
Automation (5)
Bankruptcy (107)
Best Places to Work (4825)
BIOSECURE Act (5)
Biosimilars (46)
Biotechnology (232)
Bladder cancer (45)
Brain cancer (21)
Breast cancer (144)
Cancer (1357)
Cardiovascular disease (116)
Career advice (146)
Career pathing (2)
CAR-T (109)
Cell therapy (316)
Cervical cancer (9)
Clinical research (42924)
Collaboration (520)
Compensation (229)
Complete response letters (14)
COVID-19 (1118)
CRISPR (37)
C-suite (151)
Cystic fibrosis (84)
Data (1428)
Denatured (11)
Depression (30)
Diabetes (128)
Diagnostics (1530)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (81)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (83)
Earnings (31904)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (50559)
Executive appointments (416)
FDA (7093)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (478)
Gene editing (90)
Generative AI (9)
Gene therapy (236)
GLP-1 (368)
Government (1155)
Grass and pollen (2)
Guidances (21)
Healthcare (7159)
Huntington's disease (21)
IgA nephropathy (22)
Immunology and inflammation (85)
Indications (19)
Infectious disease (1187)
Inflammatory bowel disease (111)
Inflation Reduction Act (8)
Influenza (25)
Intellectual property (66)
Interviews (19)
IPO (7702)
IRA (11)
Job creations (943)
Job search strategy (140)
Kidney cancer (6)
Labor market (4)
Layoffs (209)
Leadership (3)
Legal (1552)
Liver cancer (35)
Lung cancer (188)
Lymphoma (85)
Machine learning (1)
Management (7)
Manufacturing (121)
MASH (51)
Medical device (3232)
Medtech (3234)
Mergers & acquisitions (6935)
Metabolic disorders (373)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (63)
Neuropsychiatric disorders (23)
Neuroscience (1260)
NextGen: Class of 2025 (2125)
Non-profit (947)
Northern California (1602)
Now hiring (21)
Obesity (188)
Opinion (101)
Ovarian cancer (61)
Pain (42)
Pancreatic cancer (51)
Parkinson's disease (111)
Partnered (9)
Patents (121)
Patient recruitment (72)
Peanut (36)
People (26888)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14948)
Phase II (19858)
Phase III (12818)
Pipeline (773)
Podcasts (47)
Policy (39)
Postmarket research (934)
Preclinical (6171)
Press Release (30)
Prostate cancer (62)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (290)
Real estate (1601)
Recruiting (12)
Regulatory (9380)
Reports (16)
Research institute (995)
Resumes & cover letters (18)
Rett syndrome (4)
RNA editing (4)
RSV (10)
Schizophrenia (56)
Series A (93)
Series B (60)
Service/supplier (1)
Sickle cell disease (43)
Southern California (1426)
Special edition (11)
Spinal muscular atrophy (118)
Sponsored (11)
Startups (2047)
State (1)
Stomach cancer (4)
Supply chain (18)
Tariffs (3)
The Weekly (35)
United States (12642)
Vaccines (229)
Venture capitalists (28)
Webinars (7)
Weight loss (107)
Women's health (16)
Worklife (2)
Date
Today (37)
Last 7 days (418)
Last 30 days (1627)
Last 365 days (20664)
2025 (5110)
2024 (21377)
2023 (23540)
2022 (28740)
2021 (29384)
2020 (25005)
2019 (17590)
2018 (12862)
2017 (15013)
2016 (13152)
2015 (15770)
2014 (11418)
2013 (8423)
2012 (8569)
2011 (8591)
2010 (8241)
Location
Africa (176)
Alabama (38)
Alaska (2)
Arizona (57)
Arkansas (5)
Asia (20354)
Australia (7033)
California (3642)
Canada (1135)
China (341)
Colorado (139)
Connecticut (144)
Delaware (90)
Europe (41527)
Florida (437)
Georgia (110)
Idaho (18)
Illinois (216)
India (11)
Indiana (95)
Iowa (1)
Japan (76)
Kansas (61)
Kentucky (5)
Louisiana (4)
Maine (16)
Maryland (449)
Massachusetts (2908)
Michigan (70)
Minnesota (161)
Mississippi (1)
Missouri (25)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (940)
New Mexico (12)
New York (1017)
North Carolina (538)
North Dakota (4)
Northern California (1602)
Ohio (108)
Oklahoma (9)
Oregon (21)
Pennsylvania (688)
Puerto Rico (3)
Rhode Island (15)
South America (245)
South Carolina (4)
Southern California (1426)
Tennessee (27)
Texas (426)
Utah (51)
Virginia (72)
Washington D.C. (28)
Washington State (329)
Wisconsin (13)
288,568 Results for "specialised therapeutics australia".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Regulatory
Biogen, Eisai’s Leqembi Suffers Overseas Setbacks as UK Denies Coverage, Australia Denies Approval
Days after suffering a rejection in Australia, the Alzheimer’s drug hit another roadblock in the U.K., which found the drug not cost-effective.
March 7, 2025
·
2 min read
·
Tristan Manalac
Specialised Therapeutics signs exclusive agreement with Ascendis Pharma A/S for distribution and commercialisation of three endocrinology therapies in Australia and select South-East Asia countries
Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd has added three new endocrinology therapies to its specialist portfolio, following an exclusive distribution agreement with Danish company Ascendis Pharma A/S.
January 7, 2024
·
10 min read
Press Releases
NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia
April 2, 2025
·
5 min read
Press Releases
Allogene Therapeutics Expands Strategic Partnership with Foresight Diagnostics to Advance Joint Development Activities Outside the US Across Europe, UK, Canada, and Australia
February 26, 2025
·
7 min read
Press Releases
Exicure, Inc. (Nasdaq: XCUR) Announces Issuance of New Patent in Australia
March 14, 2025
·
2 min read
Press Releases
Novotech Named Best Contract Research Organization in Australia at Asia-Pacific Biopharma Excellence Awards 2025
March 24, 2025
·
2 min read
Specialised Therapeutics signs exclusive license agreement with CanariaBio for new ovarian cancer therapy
Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd has signed a license deal with Korea-based CanariaBio Inc., acquiring the exclusive license to a new monoclonal antibody therapy for patients with ovarian cancer in Australia, New Zealand and in select Southeast Asian countries.
October 12, 2023
·
5 min read
Deals
Specialised Therapeutics acquires commercialisation rights to new oral MND therapy
Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd will partner with Netherlands based biotechnology company Treeway BV to commercialise a new therapy to treat Amyotrophic Lateral Sclerosis – the most common form of Motor Neurone Disease - in Australia and New Zealand.
August 27, 2023
·
4 min read
Press Releases
SMSbiotech Receives Green Light for Phase I Clinical Trial in Australia, Targeting COPD
March 18, 2025
·
2 min read
Press Releases
Junshi Biosciences Announces Toripalimab’s Approval in Australia
January 17, 2025
·
9 min read
1 of 28,857
Next
